Abstract
Twenty-four patients with Raynaud's phenomenon and scleroderma were randomly assigned to receive finger temperature biofeedback, frontalis EMG biofeedback, or autogenic training. Only those receiving temperature feedback showed significant increases in finger temperature during training and during a posttraining test of voluntary control, effects not attributable to general relaxation. However, no group demonstrated significant clinical improvement, assessed by symptom reports and by ambulatory monitoring of finger temperature. The need for careful classification of patients with Raynaud's disease and Raynaud's phenomenon in scleroderma is emphasized.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adair, J., and Theobald, D. (1978). Raynaud's phenomenon: Treatment of a severe case with biofeedback.J. Ind. State Med. Assoc. 71: 990–993.
American Rheumatism Association (1981). Preliminary criteria for the classification of systemic sclerosis (scleroderma).Bull. Rheum. Dis. 31: 1–6.
Coffman, J. D. (1979). Vasodilator drugs in peripheral vascular disease.N. Engl. J. Med. 300: 713–719.
Coffman, J., and Cohen, A. (1971). Total and capillary fingertip blood flow in Raynaud's phenomenon.N. Engl. J. Med. 285: 259–263.
Freedman, R., and Ianni, P. (1983). Self-control of digital temperature: Physiological factors and transfer effects.Psychophysiology 20: 682–688.
Freedman, R., and Wenig, P. (1982). Pathophysiology and behavioral treatment of scleroderma. In Surwit, R., Williams, R. B., Steptoe, A., and Biersner, R. (eds.),Behavioral Treatment of Disease, Plenum, New York.
Freedman, R., Lynn, S., Ianni, P., and Hale, P. (1981). Biofeedback treatment of Raynaud's disease and phenomenon.Biofeedback Self-Regul. 6: 355–365.
Freedman, R., Lynn, S., and Ianni, P. (1982). Raynaud's disease. In Keefe, F., and Blumenthal, J. (eds.),Assessment Strategies in Behavioral Medicine, Grune and Stratton, New York.
Freedman, R., Ianni, P., and Wenig, P. (1983). Behavioral treatment of Raynaud's disease.J. Consult. Clin. Psychol. 51: 539–549.
Kramer, C. (1957). Extension of multiple range tests to group correlated adjusted means.Biometrics 13: 13–18.
Maricq, H., LeRoy, E., D'Angelo, W.,et al. (1980). Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders.Arth. Rheum. 61: 862–870.
Rodeheffer, R., Ronnver, J., Wrigley, F.,et al. (1983). Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.N. Engl. J. Med. 309: 880–883.
Rodnan, G. (1979). Progressive systemic sclerosis (scleroderma). In McCarty, D. (ed.),Arthritis and Allied Conditions, Lea and Febiger, Philadelphia.
Smith, C. D., and McKendry, R. J. R. (1982). Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.Lancet 2: 1299–1301.
Surwit, R., Pilon, R., and Fenton, C. (1978). Behavioral treatment of Raynaud's disease.J. Behav. Med. 1: 323–335.
Surwit, R., Allen, L., Gilgor, R., and Duvic, M. (1982). The combined effect of prazosin and autogenic training on cold reactivity in Raynaud's phenomenon.Biofeedback Self-Regul. 7: 537–544.
Author information
Authors and Affiliations
Additional information
This research was supported by Grant HL23828 from the National Heart, Lung and Blood Institute.
Rights and permissions
About this article
Cite this article
Freedman, R.R., Ianni, P. & Wenig, P. Behavioral treatment of Raynaud's phenomenon in scleroderma. J Behav Med 7, 343–353 (1984). https://doi.org/10.1007/BF00845268
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00845268